Stockreport

European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patientsCardioMEMS is a paperclip-sized se [Read more]